SNY - Sanofi
This page shows which of the focused investors we track hold SNY and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2016 it was held by 7 managers with an aggregate reported value of $2.74B, which is 0.39% of the combined portfolio.
As of Q2 2016, 7 tracked institutional managers held SNY (Sanofi) with an aggregate reported value of $2.74B — 0.39% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SNY — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2016
- Ticker
- SNY
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 2.28% | Add +3.0% | 55,155,913 | $2.31B |
| 2 | Bill Nygren - Oakmark Funds | 0.47% | Add +0.0% | 5,572,075 | $233.19M |
| 3 | Warren Buffett - Berkshire Hathaway | 0.13% | - | 3,905,875 | $163.46M |
| 4 | Francis Chou - Chou Associates | 2.28% | - | 410,000 | $17.16M |
| 5 | Sarah Ketterer - Causeway Capital Management | 0.35% | Add +0.6% | 393,781 | $16.48M |
| 6 | Christopher Bloomstran - Semper Augustus | 3.08% | Add +23.3% | 101,539 | $4.25M |
| 7 | Lee Ainslie - Maverick Capital | 0.02% | New | 42,790 | $1.79M |
Loading holder history for SNY…